Magnetic brain pulses aim to quiet suicidal urges

NCT ID NCT04130958

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether a noninvasive brain stimulation technique called iTBS-TMS can reduce suicide risk in adults with major depression or borderline personality disorder who are experiencing suicidal thoughts. Participants receive either real or sham (placebo) stimulation to a brain region linked to suicide risk. The goal is to see if this approach changes brain activity and lowers suicidal behavior.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS), a noninvasive brain stimulation technique using a magnetic coil to activate specific brain regions
What this could lead to
If it works, this could point toward a new, noninvasive treatment to lower suicide risk in people with depression or borderline personality disorder.
What could go wrong
This is an early-stage study with a small number of participants, so results may not apply broadly. The sham (placebo) group helps test effectiveness, but the treatment may not reduce suicidal thoughts or behaviors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts General Hospital

    Boston, Massachusetts, 02129, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.